Welcome to our dedicated page for Unitedhealth Gp SEC filings (Ticker: UNH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Decoding UnitedHealth Group’s layered insurance premiums, Optum analytics, and shifting medical cost ratios across hundreds of pages can drain even seasoned analysts. Need UnitedHealth Group insider trading Form 4 transactions before policy changes hit the headlines, or a quick view of the UnitedHealth Group quarterly earnings report 10-Q filing without combing through EDGAR? Stock Titan eliminates the paperwork burden.
Our AI engine reads every disclosure the moment it posts, turning dense text into plain English highlights. You’ll see UnitedHealth Group Form 4 insider transactions real-time, get UnitedHealth Group SEC filings explained simply, and access understanding UnitedHealth Group SEC documents with AI cards that surface what drives margin shifts, membership growth, and Optum revenue. Whether you’re tracking an UnitedHealth Group 8-K material events explained alert or comparing Rx benefit trends across quarters, the platform keeps all angles covered.
Investors rely on these insights to spot reimbursement risks, follow capital deployment, and gauge management incentives. The site connects each filing type to questions you actually ask:
- UnitedHealth Group annual report 10-K simplified � risk factors, medical cost ratio trends, Optum profitability.
- UnitedHealth Group earnings report filing analysis � quarter-over-quarter membership shifts and cash flow.
- UnitedHealth Group proxy statement executive compensation � incentive structures tied to quality outcomes.
With real-time updates, expert tagging, and AI-powered summaries, Stock Titan turns every disclosure into actionable clarity—so you can move from reading to decision-making faster.
UnitedHealth Group reported second-quarter 2025 consolidated revenue of $111.6 billion, up 13% from $98.9 billion a year earlier, driven by premium growth (+14% to $87.9 billion), Optum Rx volume growth and pricing trends. Despite higher revenue, earnings from operations fell to $5.15 billion (down 35%) and net earnings were $3.57 billion (diluted EPS $3.74), reflecting elevated medical costs and Medicare Advantage funding pressures.
Medical costs rose 20% to $78.6 billion for the quarter, pushing the medical care ratio to 89.4% from 85.1%. Year-to-date results show net earnings of $10.05 billion and diluted EPS of $10.61, strong cash from operations of $12.6 billion for six months, available liquidity of about $77.3 billion in cash and investments, a June dividend increase to an $8.84 annual rate, $3.0 billion of senior notes issued in June, and approximately $4 billion of anticipated acquisition capital committed (subject to approvals).
FAQ
What is the current stock price of Unitedhealth Gp (UNH)?
What is the market cap of Unitedhealth Gp (UNH)?
